| UniProt ID | FKBP3_HUMAN | |
|---|---|---|
| UniProt AC | Q00688 | |
| Protein Name | Peptidyl-prolyl cis-trans isomerase FKBP3 | |
| Gene Name | FKBP3 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 224 | |
| Subcellular Localization | Nucleus. | |
| Protein Description | FK506- and rapamycin-binding proteins (FKBPs) constitute a family of receptors for the two immunosuppressants which inhibit T-cell proliferation by arresting two distinct cytoplasmic signal transmission pathways. PPIases accelerate the folding of proteins.. | |
| Protein Sequence | MAAAVPQRAWTVEQLRSEQLPKKDIIKFLQEHGSDSFLAEHKLLGNIKNVAKTANKDHLVTAYNHLFETKRFKGTESISKVSEQVKNVKLNEDKPKETKSEETLDEGPPKYTKSVLKKGDKTNFPKKGDVVHCWYTGTLQDGTVFDTNIQTSAKKKKNAKPLSFKVGVGKVIRGWDEALLTMSKGEKARLEIEPEWAYGKKGQPDAKIPPNAKLTFEVELVDID | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 2 | Acetylation | ------MAAAVPQRA ------CCCCCCCCC | 12.25 | 25944712 | |
| 9 | Ubiquitination | AAAVPQRAWTVEQLR CCCCCCCCCCHHHHH | 10.88 | 23000965 | |
| 11 | Phosphorylation | AVPQRAWTVEQLRSE CCCCCCCCHHHHHHC | 17.12 | 27251275 | |
| 15 | Ubiquitination | RAWTVEQLRSEQLPK CCCCHHHHHHCCCCH | 4.04 | 23000965 | |
| 16 | Methylation | AWTVEQLRSEQLPKK CCCHHHHHHCCCCHH | 37.53 | - | |
| 19 | Ubiquitination | VEQLRSEQLPKKDII HHHHHHCCCCHHHHH | 65.40 | 23000965 | |
| 22 | 2-Hydroxyisobutyrylation | LRSEQLPKKDIIKFL HHHCCCCHHHHHHHH | 72.21 | - | |
| 22 | Ubiquitination | LRSEQLPKKDIIKFL HHHCCCCHHHHHHHH | 72.21 | 22817900 | |
| 23 | Ubiquitination | RSEQLPKKDIIKFLQ HHCCCCHHHHHHHHH | 52.82 | 22817900 | |
| 27 | Ubiquitination | LPKKDIIKFLQEHGS CCHHHHHHHHHHHCC | 40.11 | 22817900 | |
| 34 | Phosphorylation | KFLQEHGSDSFLAEH HHHHHHCCCCHHHHH | 31.80 | 23401153 | |
| 36 | Phosphorylation | LQEHGSDSFLAEHKL HHHHCCCCHHHHHHH | 24.69 | 29255136 | |
| 42 | Ubiquitination | DSFLAEHKLLGNIKN CCHHHHHHHHHHHHH | 36.59 | 23000965 | |
| 48 | Malonylation | HKLLGNIKNVAKTAN HHHHHHHHHHHHHCC | 49.74 | 26320211 | |
| 48 | Ubiquitination | HKLLGNIKNVAKTAN HHHHHHHHHHHHHCC | 49.74 | 23000965 | |
| 48 | Succinylation | HKLLGNIKNVAKTAN HHHHHHHHHHHHHCC | 49.74 | 23954790 | |
| 52 | Ubiquitination | GNIKNVAKTANKDHL HHHHHHHHHCCHHHH | 43.84 | 23000965 | |
| 56 | Acetylation | NVAKTANKDHLVTAY HHHHHCCHHHHHHHH | 44.02 | 26051181 | |
| 70 | Succinylation | YNHLFETKRFKGTES HHHHHHCCCCCCCHH | 48.95 | 23954790 | |
| 70 | 2-Hydroxyisobutyrylation | YNHLFETKRFKGTES HHHHHHCCCCCCCHH | 48.95 | - | |
| 70 | Ubiquitination | YNHLFETKRFKGTES HHHHHHCCCCCCCHH | 48.95 | 33845483 | |
| 70 | Acetylation | YNHLFETKRFKGTES HHHHHHCCCCCCCHH | 48.95 | 26051181 | |
| 73 | 2-Hydroxyisobutyrylation | LFETKRFKGTESISK HHHCCCCCCCHHHHH | 69.80 | - | |
| 75 | Phosphorylation | ETKRFKGTESISKVS HCCCCCCCHHHHHHH | 27.44 | 30108239 | |
| 77 | Phosphorylation | KRFKGTESISKVSEQ CCCCCCHHHHHHHHH | 31.81 | 21712546 | |
| 79 | Phosphorylation | FKGTESISKVSEQVK CCCCHHHHHHHHHHH | 35.96 | 30108239 | |
| 80 | Acetylation | KGTESISKVSEQVKN CCCHHHHHHHHHHHC | 48.38 | 25953088 | |
| 80 | Ubiquitination | KGTESISKVSEQVKN CCCHHHHHHHHHHHC | 48.38 | 33845483 | |
| 82 | Phosphorylation | TESISKVSEQVKNVK CHHHHHHHHHHHCCC | 26.50 | 20068231 | |
| 86 | Ubiquitination | SKVSEQVKNVKLNED HHHHHHHHCCCCCCC | 56.57 | 33845483 | |
| 86 | Acetylation | SKVSEQVKNVKLNED HHHHHHHHCCCCCCC | 56.57 | 25953088 | |
| 89 | Acetylation | SEQVKNVKLNEDKPK HHHHHCCCCCCCCCC | 55.80 | 25953088 | |
| 98 | Phosphorylation | NEDKPKETKSEETLD CCCCCCCCCCHHHCC | 46.10 | 26657352 | |
| 99 | Ubiquitination | EDKPKETKSEETLDE CCCCCCCCCHHHCCC | 57.89 | 33845483 | |
| 99 | Acetylation | EDKPKETKSEETLDE CCCCCCCCCHHHCCC | 57.89 | 26822725 | |
| 100 | Phosphorylation | DKPKETKSEETLDEG CCCCCCCCHHHCCCC | 48.35 | 29255136 | |
| 103 | Phosphorylation | KETKSEETLDEGPPK CCCCCHHHCCCCCCC | 35.14 | 29255136 | |
| 110 | Acetylation | TLDEGPPKYTKSVLK HCCCCCCCCCHHHHH | 69.55 | 23236377 | |
| 111 | Phosphorylation | LDEGPPKYTKSVLKK CCCCCCCCCHHHHHC | 25.77 | 29083192 | |
| 112 | Phosphorylation | DEGPPKYTKSVLKKG CCCCCCCCHHHHHCC | 23.99 | 29083192 | |
| 114 | Phosphorylation | GPPKYTKSVLKKGDK CCCCCCHHHHHCCCC | 25.53 | 29083192 | |
| 127 | Ubiquitination | DKTNFPKKGDVVHCW CCCCCCCCCCEEEEE | 61.66 | 23000965 | |
| 132 | Ubiquitination | PKKGDVVHCWYTGTL CCCCCEEEEEEEEEE | 9.02 | 23000965 | |
| 133 | Glutathionylation | KKGDVVHCWYTGTLQ CCCCEEEEEEEEEEC | 1.69 | 22555962 | |
| 135 | Phosphorylation | GDVVHCWYTGTLQDG CCEEEEEEEEEECCC | 10.73 | 24732914 | |
| 136 | Phosphorylation | DVVHCWYTGTLQDGT CEEEEEEEEEECCCC | 10.13 | 24732914 | |
| 137 | Ubiquitination | VVHCWYTGTLQDGTV EEEEEEEEEECCCCE | 14.56 | 23000965 | |
| 138 | Phosphorylation | VHCWYTGTLQDGTVF EEEEEEEEECCCCEE | 17.28 | 24732914 | |
| 143 | Phosphorylation | TGTLQDGTVFDTNIQ EEEECCCCEEECCCC | 26.70 | 24732914 | |
| 147 | Phosphorylation | QDGTVFDTNIQTSAK CCCCEEECCCCCCCC | 23.82 | 27794612 | |
| 151 | Phosphorylation | VFDTNIQTSAKKKKN EEECCCCCCCCCCCC | 27.19 | 30266825 | |
| 152 | Phosphorylation | FDTNIQTSAKKKKNA EECCCCCCCCCCCCC | 23.01 | 30266825 | |
| 154 | Ubiquitination | TNIQTSAKKKKNAKP CCCCCCCCCCCCCCC | 65.96 | 32015554 | |
| 154 | Acetylation | TNIQTSAKKKKNAKP CCCCCCCCCCCCCCC | 65.96 | 25953088 | |
| 160 | Ubiquitination | AKKKKNAKPLSFKVG CCCCCCCCCCEEEEC | 56.75 | 23000965 | |
| 160 | Acetylation | AKKKKNAKPLSFKVG CCCCCCCCCCEEEEC | 56.75 | 23749302 | |
| 160 | Malonylation | AKKKKNAKPLSFKVG CCCCCCCCCCEEEEC | 56.75 | 26320211 | |
| 163 | Phosphorylation | KKNAKPLSFKVGVGK CCCCCCCEEEECCHH | 31.39 | 28464451 | |
| 165 | Malonylation | NAKPLSFKVGVGKVI CCCCCEEEECCHHHH | 34.40 | 26320211 | |
| 165 | Acetylation | NAKPLSFKVGVGKVI CCCCCEEEECCHHHH | 34.40 | 25953088 | |
| 165 | Ubiquitination | NAKPLSFKVGVGKVI CCCCCEEEECCHHHH | 34.40 | 23000965 | |
| 170 | 2-Hydroxyisobutyrylation | SFKVGVGKVIRGWDE EEEECCHHHHCCHHH | 31.89 | - | |
| 170 | Acetylation | SFKVGVGKVIRGWDE EEEECCHHHHCCHHH | 31.89 | 19608861 | |
| 170 | Ubiquitination | SFKVGVGKVIRGWDE EEEECCHHHHCCHHH | 31.89 | 23000965 | |
| 170 | Malonylation | SFKVGVGKVIRGWDE EEEECCHHHHCCHHH | 31.89 | 26320211 | |
| 173 | Methylation | VGVGKVIRGWDEALL ECCHHHHCCHHHHHE | 43.04 | - | |
| 181 | Phosphorylation | GWDEALLTMSKGEKA CHHHHHEEECCCCCE | 21.90 | 20068231 | |
| 182 | Sulfoxidation | WDEALLTMSKGEKAR HHHHHEEECCCCCEE | 3.83 | 30846556 | |
| 183 | Phosphorylation | DEALLTMSKGEKARL HHHHEEECCCCCEEE | 32.07 | 20068231 | |
| 187 | Methylation | LTMSKGEKARLEIEP EEECCCCCEEEEECC | 47.69 | 23644510 | |
| 198 | Phosphorylation | EIEPEWAYGKKGQPD EECCHHHCCCCCCCC | 30.47 | 20068231 | |
| 200 | 2-Hydroxyisobutyrylation | EPEWAYGKKGQPDAK CCHHHCCCCCCCCCC | 40.84 | - | |
| 200 | Ubiquitination | EPEWAYGKKGQPDAK CCHHHCCCCCCCCCC | 40.84 | 32015554 | |
| 200 | Malonylation | EPEWAYGKKGQPDAK CCHHHCCCCCCCCCC | 40.84 | 26320211 | |
| 200 | Acetylation | EPEWAYGKKGQPDAK CCHHHCCCCCCCCCC | 40.84 | 23749302 | |
| 201 | Ubiquitination | PEWAYGKKGQPDAKI CHHHCCCCCCCCCCC | 59.42 | - | |
| 207 | Ubiquitination | KKGQPDAKIPPNAKL CCCCCCCCCCCCCEE | 64.23 | 33845483 |
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of FKBP3_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of FKBP3_HUMAN !! | ||||||
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Acetylation | |
| Reference | PubMed |
| "Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, AND MASS SPECTROMETRY. | |
| "Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-160 AND LYS-170, AND MASSSPECTROMETRY. | |
| Phosphorylation | |
| Reference | PubMed |
| "A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-152, AND MASSSPECTROMETRY. | |